blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1326585

EP1326585 - METHOD FOR PRODUCING POWDERY FORMULATIONS [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  27.08.2010
Database last updated on 22.08.2024
Most recent event   Tooltip27.08.2010Patent maintained (B2 publication)published on 29.09.2010  [2010/39]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
55216 Ingelheim am Rhein / DE
[2006/10]
Former [2003/29]For all designated states
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
55216 Ingelheim am Rhein / DE
Inventor(s)01 / BÖCK, Georg
Benjamin-Franklin-Strasse 8
55122 Mainz / DE
02 / WALZ, Michael
Prizrenstrasse 22
55411 Bingen am Rhein / DE
 [2003/29]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2008/31]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2007/37]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date01986599.709.10.2001
[2003/29]
WO2001EP11636
Priority number, dateDE2000105063512.10.2000         Original published format: DE 10050635
DE2001103802210.08.2001         Original published format: DE 10138022
[2003/29]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO0230390
Date:18.04.2002
Language:DE
[2002/16]
Type: A2 Application without search report 
No.:EP1326585
Date:16.07.2003
Language:DE
The application published by WIPO in one of the EPO official languages on 18.04.2002 takes the place of the publication of the European patent application.
[2003/29]
Type: B1 Patent specification 
No.:EP1326585
Date:08.03.2006
Language:DE
[2006/10]
Type: B2 New European patent specification 
No.:EP1326585
Date:29.09.2010
Language:DE
[2010/39]
Search report(s)International search report - published on:EP27.06.2002
ClassificationIPC:A61K9/00, A61K9/14
[2003/29]
CPC:
A61K9/0075 (EP,US); A61K9/14 (EP,KR,US); A61K31/439 (EP,US);
A61K9/145 (EP,US); A61P11/00 (EP); A61P11/06 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/29]
Extension statesAL12.05.2003
LT12.05.2003
LV12.05.2003
MK12.05.2003
RO12.05.2003
SI12.05.2003
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON PULVERFORMULIERUNGEN[2003/29]
English:METHOD FOR PRODUCING POWDERY FORMULATIONS[2003/29]
French:PROCEDE DE PREPARATION DE FORMULATIONS PULVERULENTES[2003/29]
Entry into regional phase12.05.2003National basic fee paid 
12.05.2003Designation fee(s) paid 
12.05.2003Examination fee paid 
Examination procedure16.04.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.05.2003Examination requested  [2003/29]
16.08.2005Communication of intention to grant the patent
27.12.2005Fee for grant paid
27.12.2005Fee for publishing/printing paid
Opposition(s)Opponent(s)01  08.12.2006    ADMISSIBLE
AstraZeneca AB
151 85 Södertälje / SE
Opponent's representative
Summersell, Richard John, et al, et al
AstraZeneca AB, Global Intellectual Property
151 85 Södertälje / SE
 02  08.12.2006    ADMISSIBLE
PFIZER LIMITED
Ramsgate Road
SANDWICH, KENT CT13 9NJ / GB
Opponent's representative
Laurent, Claire, et al, et al
Pfizer
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
 [N/P]
Former [2007/03]
Opponent(s)01  08.12.2006    ADMISSIBLE
AstraZeneca AB
151 85 Södertälje / SE
Opponent's representative
Summersell, Richard John, et al, et al
AstraZeneca AB, Global Intellectual Property
151 85 Södertälje / SE
 02  08.12.2006    ADMISSIBLE
PFIZER LIMITED
Ramsgate Road
SANDWICH, KENT CT13 9NJ / GB
Opponent's representative
Laurent, Claire, et al, et al
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
12.01.2007Invitation to proprietor to file observations on the notice of opposition
24.09.2007Reply of patent proprietor to notice(s) of opposition
13.05.2009Date of oral proceedings
25.06.2009Despatch of interlocutory decision in opposition
25.06.2009Despatch of minutes of oral proceedings
28.04.2010Legal effect of interlocutory decision in opposition
07.06.2010Despatch of communication that the patent will be maintained as amended
13.08.2010Fee for printing new specification paid
Appeal following opposition19.08.2009Appeal received No.  T1802/09
28.04.2010Result of appeal procedure: appeal of the proprietor was rejected
Fees paidRenewal fee
31.10.2003Renewal fee patent year 03
02.11.2004Renewal fee patent year 04
31.10.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/50]
Former [2007/37]IT08.03.2006
Cited inInternational search[Y]WO9311746  (BOEHRINGER INGELHEIM INT [DE], et al) [Y] 1,2,4-9 * claims 1-6 * * page 4, paragraph 3 - paragraph 5 ** examples 1,2 *;
 [XY]DE4425255  (ASTA MEDICA AG [DE]) [X] 1,2,5,8,9 * claim 1 * * examples 4,5 * [Y] 1,2,4-9
OppositionUS4515805
 WO9511666
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.